Characteristics of the 16 patients with SLE at the start of IAS treatment
| Characteristics | |
|---|---|
| GN, glomerulonephritis; IVCP, intravenous pulse cyclophosphamide. | |
| Age (years), mean (SD) | 30 (11) |
| Female, No (%) | 14 (88) |
| White, No (%) | 14 (88) |
| East Asian, No (%) | 2 (13) |
| Disease duration (years), mean (SD) | 6.4 (8.1) |
| SIS, mean (SD) | 15 (6) |
| Major organ involvement, No (%) | |
| Cerebral | 6 (38) |
| Lung | 7 (44) |
| Renal | 16 (100) |
| Renal biopsy, No (%) | 14 (88) |
| GN WHO II | 1 |
| GN WHO III | 1 |
| GN WHO IV | 10 |
| GN WHO V | 2 |
| Indication for IAS, No (%) | |
| Disease progression despite IVCP | 9 (56) |
| IVCP contraindicated or denied | 7 (44) |